TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 31 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $0 | – | 3,925 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 3,925 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 3,925 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 3,925 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 3,925 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 3,925 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 3,925 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 3,925 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 3,925 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 3,925 | 0.0% | 0.00% | – |
Q3 2016 | $0 | -100.0% | 3,925 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | – | 3,925 | 0.0% | 0.00% | – |
Q1 2016 | $0 | -100.0% | 3,925 | 0.0% | 0.00% | – |
Q4 2015 | $6,000 | -14.3% | 3,925 | 0.0% | 0.00% | – |
Q3 2015 | $7,000 | -22.2% | 3,925 | 0.0% | 0.00% | – |
Q2 2015 | $9,000 | -47.1% | 3,925 | 0.0% | 0.00% | – |
Q1 2015 | $17,000 | -5.6% | 3,925 | 0.0% | 0.00% | – |
Q4 2014 | $18,000 | +12.5% | 3,925 | 0.0% | 0.00% | – |
Q3 2014 | $16,000 | -30.4% | 3,925 | 0.0% | 0.00% | – |
Q2 2014 | $23,000 | – | 3,925 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Clarus Ventures, LLC | 4,644,705 | $19,322,000 | 7.71% |
First Washington CORP | 185,250 | $771,000 | 0.44% |
SPHERA FUNDS MANAGEMENT LTD. | 194,200 | $808,000 | 0.10% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 286,801 | $1,173,000 | 0.05% |
EMERALD ADVISERS, LLC | 175,000 | $728,000 | 0.04% |
Pine River Capital Management L.P. | 209,900 | $873,000 | 0.01% |
Alyeska Investment Group, L.P. | 79,196 | $329,000 | 0.01% |
HighTower Advisors, LLC | 66,514 | $277,000 | 0.01% |
Tower Research Capital LLC (TRC) | 1,441 | $6,000 | 0.00% |
First Eagle Investment Management, LLC | 114,456 | $476,000 | 0.00% |